期刊文献+

磺达肝素预防术后肺血栓栓塞的荟萃分析 被引量:1

Fondaparinux prevention of pulmonary thromboembolism after surgery:a Meta-analysis
下载PDF
导出
摘要 目的:评估磺达肝素对术后发生肺血栓栓塞(PTE)的预防作用,并系统分析磺达肝素和一般低分子肝素(LMWH)疗效和安全性的差异。方法:从Medline、Cochrane图书馆和中国生物医学文献数据库(CBM)检索公开发表的文章(2000年1月—2007年6月),以磺达肝素或LMWH类药物(对照)预防术后PTE的随机对照试验(RCT)为研究对象,采用Rev Man 4.2软件进行统计分析。结果:对符合纳入标准的5篇文献共10 271例病人进行荟萃分析,根据意向性分析(ITT)磺达肝素组和对照组术后PTE发病率分别为0.31%和0.25%,2组比数比(OR)为1.23(95%CI为0.59~2.57),差异无显著意义(P>0.05)。2组术后严重出血发生率分别为2.82%和1.89%,OR值为1.51(95%CI为0.73~1.83),差异有显著意义(P<0.01)。2组术后轻微出血发生率分别为2.73%和2.37%,OR值为1.15(95%CI为0.90~1.48),差异无显著意义(P>0.05)。结论:磺达肝素预防术后PTE的疗效与一般LMWH相当,两者术后轻微出血发生率相似,但磺达肝素引起术后严重出血的危险性相对较高。 AIM: To assess the efficacy and safety of fondaparinux versus low molecular weight heparin (LMWH) for the prevention of pulmonary thromboembolism (PTE) after surgery. METHODS: All the randomized controlled trials (RCT) of 'fondaparinux' or 'LMWH' in prevention of PTE after surgery from Medline, the Cochrane Library, CMB (January 2000 to June 2007) were comprehensively undertaken with furthermore Meta-analysis conducted on combining the odd ratios of the individual studies through Rev Man 4.2 software statistically. RESULTS: Of the 5 standardized articles screened, 10 271 cases were included in the Meta-analysis with the occurrence rates of PTE after surgery (intention-to-treat, ITT) in fondaparinux group as 0.31% vs control group 0.25 %, the odds ratio (OR) outcoming 1.23 (95 % CI was 0.59-2.57), with no statistical significance (P 〉 0.05) . The incidence of major bleeding after surgery of the two groups were 2.82 % and 1.89 %, respectively, the OR was 1.51 (95 % CI was 0.73-1.83), with statistically significant difference (P 〈 0.01) . The incidence of minor bleeding after surgery of the two groups were 2.73 % and 2.37 %, respectively, with OR 1.15 (95 % CI was 0.90-1.48) , having no statistical significance (P 〉 0.05) . CONCLUSION: Fondaparinux is as effective as LMWH in prevention of PTE after surgery, similar the risk of minor bleeding after surgery, but with a high risk of severe bleeding after surgery in comparing with LMWH.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2007年第11期832-837,共6页 Chinese Journal of New Drugs and Clinical Remedies
关键词 磺达肝素 肺栓塞 出血 随机对照试验 综合分析 fondaparinux pulmonary embolism hemorrhage randomized controlled trials Meta-analysis
  • 相关文献

参考文献19

  • 1翟振国,王辰.肺血栓栓塞症的研究进展[J].中华结核和呼吸杂志,2004,27(1):14-18. 被引量:41
  • 2MISMETTI P, LAPORTE S, DARMON JY, et al. Meta-analysis of low molecular weight heparin in the prevention of venous thmmboembolism in general surgery[J]. Br J Surg, 2001, 88(7) : 913-930.
  • 3CLAGETT GP, REISCH JS. Prevention of venous thromboem-bolism in general surgical patients. Results of meta-analysis[J].Ann Surg, 1988, 208(2): 227-240.
  • 4PEZZUOLI G, NERI SERNERI GG, SETTEMBRINI P, et al. Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin Cy 216: a multicentre, doubleblind, randomized, controlled, clinical trial versus placebo (STEP)[J]. Int Surg, 1989, 74(4): 205-210.
  • 5AGNELLI G, BERGQVIST D, COHEN AT, et al. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery[J]. Br J Surg, 2005, 92(10) : 1212-1220.
  • 6JADAD AR, MOORE RA, CARROLL D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?[J]. Control Clin Trials, 1996, 17(1) : 1-12.
  • 7SONG F, ALTMAN DG, GLENNY AM, et al. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses[J]. BMJ, 2003, 326 (7387): 472.
  • 8BAUER KA, ERIKSSON BI, LASSEN MR, et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery [J]. N Engl J Med, 2001, 345 (18): 1305-1310.
  • 9ERIKSSON BI, BAUER KA, LASSEN MR, et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery [J]. N EngI J Med, 2001, 345 (18) : 1298-1304.
  • 10LASSEN MR, BAUER KA, ERIKSSON BI, et al. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-bIind comparison[J]. Lancet, 2002, 359 (9319) : 1715-1720.

二级参考文献18

  • 1ROHSS K,LIND T,WILDER-SMITH C.Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg,omeprazole 20 mg,pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms[J].Eur J Clin Pharmacol,2004,60(8):531-539.
  • 2ROHSS K,HASSELGREN G,HEDENSTROM H.Effect of esomeprazloe 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease[J].Dig Dis Sci,2002,47(5):954-958.
  • 3MALFERTHEINER P,MEGRAUD F,O'MORAIN C,et al.European Helicobacter pylori Study Group (EHPSG).Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report[J].Aliment Pharmacol Ther,2002,16(2):167-180.
  • 4JADAD AR,MOORE RA,CARROLL D,et al.Assessing the quality of reports of randomized clinical trials:Is blinding necessary?[J] Controlled Clin Trials,1996,17(1):1-12.
  • 5LAINE L,FENNERTY MB,OSATO M,et al.Esomeprazolebased Helicobacter pylori eradication therapy and the effect of antibiotic resistance:results of three US multicenter,doubleblind trials[J].Am J Gastroenterol,2000,95(12):3393-3398.
  • 6SHEU BS,KAO AW,CHENG HC,et al.Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism[J].Aliment Pharmacol Ther,2005,21(3):283-288.
  • 7MIEHLKE S,SCHNEIDER-BRACHERT W,BASTLEIN E,et al.Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance[J].Aliment Pharmacol Ther,2003,18(8):799-804.
  • 8ANAGNOSTOPOULOS GK,TSIAKOS S,MARGANTINIS G,et al.Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection:results of a randomized controlled study[J].J Clin Gastroenterol,2004,38(6):503-506.
  • 9TULASSAY Z,KRYSZEWSKI A,DITE P,et al.One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease[J].Eur J Gastroenterol Hepatol,2001,13(12):1457-1465.
  • 10VELDHUYZEN van ZANTEN S,LAURITSEN K,DELCHIER JC,et al.One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease[J].Aliment Pharmacol Ther,2000,14(12):1605-1611.

共引文献44

同被引文献4

引证文献1

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部